Production (Stage)
E
Rapid Dose Therapeutics Corp. RDTCF
$0.1393 -$0.0407-22.61% OTC PK
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

02/28/2025 11/30/2024 08/31/2024 05/31/2024 02/29/2024
Net Income -1.18M -991.90K -803.00K -922.30K -1.53M
Total Depreciation and Amortization 41.70K 35.00K 36.70K 60.70K 134.60K
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 536.00K 527.90K 350.80K 479.20K 568.10K
Change in Net Operating Assets 600.70K 235.30K 224.70K -74.30K -134.80K
Cash from Operations 3.20K -193.70K -190.80K -456.70K -961.10K
Capital Expenditure -4.00K -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -4.00K -- -- -- --
Total Debt Issued -- -- 10.90K 22.90K 123.90K
Total Debt Repaid -43.70K -240.10K -100.00K -29.10K -42.90K
Issuance of Common Stock 25.40K 475.00K 309.00K 580.50K 1.30M
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- -94.90K
Cash from Financing -12.80K 170.70K 160.60K 421.50K 957.30K
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -13.50K -23.00K -30.20K -35.20K -3.80K